On April 11, 2024, John Chevedden announced that he has filed an exempt solicitation statement with Securities and Exchange Commission, requesting the shareholders of Quest Diagnostics Incorporated to vote for a proposal regarding issue near and long-term science-based greenhouse gas reduction targets aligned with the Paris Agreement?s ambition of limiting global temperature rise to 1.5 °C and summarize plans to achieve them, at the annual meeting of shareholders scheduled to be held on May 16, 2024.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
136.3 USD | -0.88% | -0.88% | -1.12% |
May. 01 | Quest Diagnostics to Acquire PathAI Diagnostics Assets in Collaboration Deal | MT |
May. 01 | Quest Diagnostics Forms Licensing Agreements with PathAI | CI |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.12% | 15.28B | |
+14.10% | 81.84B | |
-30.15% | 70.69B | |
+9.37% | 29.03B | |
-11.90% | 16.97B | |
-0.36% | 16.83B | |
+5.90% | 12.41B | |
+35.78% | 12.26B | |
-4.20% | 11.86B | |
-31.05% | 11.83B |
- Stock Market
- Equities
- DGX Stock
- News Quest Diagnostics Incorporated
- John Chevedden Files an Exempt Solicitation Statement with Securities and Exchange Commission